US Stock MarketDetailed Quotes

KTRA Kintara Therapeutics

Watchlist
  • 0.1513
  • -0.0059-3.75%
Close May 3 16:00 ET
  • 0.1513
  • 0.00000.00%
Post 19:58 ET
5.91MMarket Cap-28P/E (TTM)

Kintara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-70.88%1.02M
-36.25%2.96M
-34.77%14.8M
-38.64%3.35M
-38.37%3.3M
-40.64%3.5M
-22.19%4.65M
5.15%22.68M
-18.50%5.46M
-18.88%5.36M
Selling and administrative expenses
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
-23.04%7.51M
-45.46%1.45M
-31.79%1.88M
-General and administrative expense
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
-23.04%7.51M
-45.46%1.45M
-31.79%1.88M
Research and development costs
-94.61%111K
-41.37%1.86M
-38.63%9.31M
-48.15%2.08M
-42.29%2.01M
-47.23%2.06M
-16.40%3.17M
28.42%15.17M
-0.67%4M
-9.60%3.47M
Operating profit
70.88%-1.02M
36.25%-2.96M
34.77%-14.8M
38.64%-3.35M
38.37%-3.3M
40.64%-3.5M
22.19%-4.65M
-5.15%-22.68M
18.50%-5.46M
18.88%-5.36M
Net non-operating interest income expense
-95.56%2K
-94.87%2K
878.57%137K
27.27%14K
3,800.00%39K
4,400.00%45K
3,800.00%39K
111.67%14K
142.31%11K
103.45%1K
Total other finance cost
95.56%-2K
94.87%-2K
-878.57%-137K
-27.27%-14K
-3,800.00%-39K
-4,400.00%-45K
-3,800.00%-39K
-111.67%-14K
-142.31%-11K
-103.45%-1K
Other net income (expense)
-6K
-118.18%-2K
42.86%10K
0
-200.00%-1K
175.00%11K
100.04%7K
111.11%1K
200.00%1K
Gain on sale of security
---6K
-118.18%-2K
42.86%10K
--0
-200.00%-1K
----
175.00%11K
158.33%7K
111.11%1K
200.00%1K
Income before tax
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
19.28%-5.36M
Income tax
Net income
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
19.28%-5.36M
Net income continuous Operations
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
19.28%-5.36M
Minority interest income
Net income attributable to the parent company
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
19.28%-5.36M
Preferred stock dividends
0.00%2K
-51.92%175K
-85.02%370K
0.00%2K
0.00%2K
0.00%2K
-85.23%364K
-22.96%2.47M
-50.00%2K
-75.00%2K
Other preferred stock dividends
Net income attributable to common stockholders
70.34%-1.03M
36.75%-3.14M
40.24%-15.02M
38.75%-3.34M
39.04%-3.27M
41.37%-3.46M
41.16%-4.96M
39.45%-25.13M
19.12%-5.45M
19.34%-5.36M
Basic earnings per share
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
67.75%-25.8
47.54%-3.41
52.61%-5.45
Diluted earnings per share
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
67.75%-25.8
47.54%-3.41
52.61%-5.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -70.88%1.02M-36.25%2.96M-34.77%14.8M-38.64%3.35M-38.37%3.3M-40.64%3.5M-22.19%4.65M5.15%22.68M-18.50%5.46M-18.88%5.36M
Selling and administrative expenses -36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M-23.04%7.51M-45.46%1.45M-31.79%1.88M
-General and administrative expense -36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M-23.04%7.51M-45.46%1.45M-31.79%1.88M
Research and development costs -94.61%111K-41.37%1.86M-38.63%9.31M-48.15%2.08M-42.29%2.01M-47.23%2.06M-16.40%3.17M28.42%15.17M-0.67%4M-9.60%3.47M
Operating profit 70.88%-1.02M36.25%-2.96M34.77%-14.8M38.64%-3.35M38.37%-3.3M40.64%-3.5M22.19%-4.65M-5.15%-22.68M18.50%-5.46M18.88%-5.36M
Net non-operating interest income expense -95.56%2K-94.87%2K878.57%137K27.27%14K3,800.00%39K4,400.00%45K3,800.00%39K111.67%14K142.31%11K103.45%1K
Total other finance cost 95.56%-2K94.87%-2K-878.57%-137K-27.27%-14K-3,800.00%-39K-4,400.00%-45K-3,800.00%-39K-111.67%-14K-142.31%-11K-103.45%-1K
Other net income (expense) -6K-118.18%-2K42.86%10K0-200.00%-1K175.00%11K100.04%7K111.11%1K200.00%1K
Gain on sale of security ---6K-118.18%-2K42.86%10K--0-200.00%-1K----175.00%11K158.33%7K111.11%1K200.00%1K
Income before tax 70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M19.28%-5.36M
Income tax
Net income 70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M19.28%-5.36M
Net income continuous Operations 70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M19.28%-5.36M
Minority interest income
Net income attributable to the parent company 70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M19.28%-5.36M
Preferred stock dividends 0.00%2K-51.92%175K-85.02%370K0.00%2K0.00%2K0.00%2K-85.23%364K-22.96%2.47M-50.00%2K-75.00%2K
Other preferred stock dividends
Net income attributable to common stockholders 70.34%-1.03M36.75%-3.14M40.24%-15.02M38.75%-3.34M39.04%-3.27M41.37%-3.46M41.16%-4.96M39.45%-25.13M19.12%-5.45M19.34%-5.36M
Basic earnings per share 88.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.3967.75%-25.847.54%-3.4152.61%-5.45
Diluted earnings per share 88.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.3967.75%-25.847.54%-3.4152.61%-5.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg